ALIGOS BELGIUM
ActiveSummary
ALIGOS BELGIUM has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €271,098. Equity has been growing by about 29% per year since 2019. Its solvency ranks better than 50% of 3,032 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 10-09-2018 Normal situation
- Activity
- Medical imaging and medical laboratories NACE 86910and 1 other
- Joint committee
- 200 Aanvullend Paritair Comité voor de bedienden · annual accounts 2025
- Establishment unit
- 2.280.023.996 3001 Leuven, since 10-09-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 02-01-2026
Board and ownership
- Sushmita ChandaDaily manager
- Julian SYMONSDirector · since 31-12-2023
- Lawrence BlattDirector · since 31-12-2023
- Auditor
- PKF Bofidi Audit
- Aligos Therapeutics Incconsolidatesannual accounts 2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €3.2m
- ▲ 9.0%
- Turnover
- ≈ €2.8m
- estimated
- Profit
- €271,098
- ▲ 0.1%
- Equity
- €1.1m
- ▼ 53.5%
- Total assets
- €1.8m
- ▼ 44.6%
- Employees on 31-12-2025
- 13
- ▲ 8.3%
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.24, cash €730,848Figures for financial year 2025 (filed on 02-07-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 36% of them on solvency, 75% on liquidity, 72% on profitability and 2% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 13 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Equity fell in 2025from €2.3m to €1.1m ▼ 53.5% View
- Higher gross margin than 95% of companies in human healthsector median €280,475 · 2,924 companies €3.2m View
- Positive: Always filed on timeaccounts within the deadline every year 7 years View
- Positive: 7 profitable years in a rowprofit 2025: €271,098 7 years View
Recent changes
- · Gazette deed Registered office moved within Leuven
- · Gazette deed Appointments: Lesley Calhoun (director) and Sushmita Chanda (day-to-day manager)
- · Gazette deed Resignation: Leonid Beigelman (director)Appointment: Lawrence Blatt (director)
Comparable companies
These companies have the same main activity as ALIGOS BELGIUM: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €1.6m and €5.3m, founded between 2011 and 2016.
| Company | Total assets | Gross margin |
|---|---|---|
| ALIGOS BELGIUM Leuven | €1.8m | €3.2m |
| InnoSer België Diepenbeek | €2.1m | €3.1m |
| EUROFINS FORENSICS BELGIUM Brugge | €3.3m | €3.2m |
| OncoDNA Charleroi | €5.3m | €2.1m |
| Harmony Clinical Research Merelbeke-Melle | €1.6m | €2.1m |
| Dokter Fr. Cuigniez - Medische Beeldvorming Gent | €3.0m | €1.6m |
| Medlab Kortrijk | €1.8m | €1.0m |
Key facts about ALIGOS BELGIUM
- What is the company number of ALIGOS BELGIUM?
- The company number of ALIGOS BELGIUM is 0702.969.886. The VAT number is the same number with BE in front: BE 0702.969.886.
- Where is ALIGOS BELGIUM based?
- The registered office is at Gaston Geenslaan 2, 3001 Leuven.Company details
- What does ALIGOS BELGIUM do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of ALIGOS BELGIUM?
- The legal form of ALIGOS BELGIUM is Private limited company (BV).
- When was ALIGOS BELGIUM founded?
- ALIGOS BELGIUM was founded on 10-09-2018.
- Is ALIGOS BELGIUM still active?
- Yes, ALIGOS BELGIUM is an active enterprise in the KBO register.
- How many employees does ALIGOS BELGIUM have?
- ALIGOS BELGIUM had an average of 12.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does ALIGOS BELGIUM fall under?
- In its 2025 annual accounts, ALIGOS BELGIUM states joint committee 200 (Aanvullend Paritair Comité voor de bedienden).
- What is the turnover of ALIGOS BELGIUM?
- The turnover in financial year 2025 is ≈ €2.8m. This figure is estimated from the gross margin of €3.2m and 64 comparable companies (NACE 86). It probably lies between €2.6m and €4.2m.
- Is ALIGOS BELGIUM profitable?
- In financial year 2025, ALIGOS BELGIUM made a profit of €271,098.
- Where can I find the annual accounts of ALIGOS BELGIUM?
- ALIGOS BELGIUM filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ALIGOS BELGIUM due?
- ALIGOS BELGIUM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.